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Abstract
Introduction: High altitude environments lead to a significant physiological challenge and
disease processes which can be life threatening; operational effectiveness at high altitude can
be severely compromised. The UK military research is investigating ways of mitigating the
physiological effects of high altitude

Methods: The British Service Dhaulagiri Research Expedition took place from March to May
2016, and the military personnel were invited to consent to a variety of study protocols
investigating adaptation to high altitudes and diagnosis of high altitude illness. The studies
took place in remote and austere environments at altitudes of up to 7500m.

Results: This paper gives an overview of the individual research protocols investigated, the
execution of the expedition and the challenges involved. 129 Servicemen and women were
involved at altitudes of up to 7500m; 8 research protocols were investigated.

Conclusions: The outputs from these studies will help to individualise the acclimatisation
process and inform strategies for pre-acclimatisation should troops ever need to deploy at
high altitude at short notice.

Introduction
The UK military runs a programme of adventurous training (AT) with the aims of promoting,
“through the conduct of arduous outdoor activities with exposure to hardship and danger, the
Army’s core values, leadership, teamwork and other qualities necessary to enhance the
Operational effectiveness of all military personnel” [1] In a quadrennial cycle the Single
Service mountaineering clubs, in rotation, lead a major expedition as an inspirational AT
activity. This is usually, but not exclusively, a mountaineering expedition to one of the world’s
fourteen 8,000m peaks (located in the Himalayan range in Nepal and Pakistan). The 2016
expedition was a Royal Navy-led trip and the opportunity was taken to mount a significant
medical research expedition to the Dhaulagiri region of Nepal - the British Services Dhaulagiri
Medical Research Expedition (BSDMRE) 2016. The expedition had support of His Royal
Highness the Duke of York and the Surgeon General.

This journal has previously published on the challenges and opportunities of research in high
altitude environments and on the potential benefits of AT.[2, 3] This research expedition was
part of ongoing UK military and civilian research with collaboration between the Royal Centre
for Defence Medicine (RCDM), Leeds Beckett University and the University of Oxford. The
studies focussed on the physiological response to high altitude (HA), the diagnosis of acute
mountain sickness (AMS) and strategies to enable the rapid deployment of troops to a HA
environment (pre-acclimatisation). This article describes the background to these studies and
the research protocols used and acts as a foundation for subsequent publication of specific
study results.

Methods
Funding

AT is formal, publicly funded military training. Participation in AT is “an integral aspect of
military training that supports the values and standards of the military thus enhances an
individual’s ability to withstand the rigours of operations”.[1] This direct public funding
contributed around 50% of the costs for each subject which in turn facilitated the relatively
large numbers for a research expedition. Research funding was supported by industry
(Medtronic Reveal Linq devices provided free of charge), public funding through RCDM,
funding from Leeds Beckett University, University of Oxford, the Mount Everest Foundation
and a grant from the Royal Navy Royal Marines Charity (RNRMC). It is exceptional for the
RNRMC to support research in this way but a large fundraising event with the support of the

Duke of York enabled the charity to raise sufficient funds to underwrite the research costs.
Additional support with kit and equipment was provided by expedition sponsors notably Honda
generators and Solarpod equipment to power the research kit described in the protocols.

Environment

For the initial part of the trek of the Dhaulagiri circuit the terrain was at low altitude (although
daily ascent was considerable) and through hot, humid pasture and rainforest. From Italian
Base camp (IBC) onwards the trek followed glaciated terrain around the western and northern
aspects of Dhaulagiri. This terrain was dry and hot during the day and cold at night.
Temperatures in the Hidden Valley (at 5140m) were frequently around -10ºC by night with
considerable wind chill. By day temperatures in the direct sun or inside tents could be as high
as +30ºC. Above IBC all precipitation fell as snow due to the low temperatures, whereas IBC
itself experienced heavy afternoon rain storms during the latter part of the expedition. All
research took place in tents as there is no hard accommodation on the circuit above IBC, and
frequently early in the morning to take measurements in the starved state. This placed a great
strain on the research teams who had to work in extreme temperatures, often clad in one piece
down suits!

Research Protocols
The pathophysiology of HA illness remains ill-defined but the rate of AMS among military
personnel ascending to HA as part of AT is significant, with 34% of those ascending Mount
Kenya suffering severe AMS in one report. [4] AMS was also a significant cause of Disease
Non-Battle Injury (DNBI) during the Battle of Taku Ghar in Afghanistan in 2002 with 18 cases
of AMS requiring casevac from theatre of operations and treatment by 274th Field Surgical
Team.[5] The programme of research on the expedition was aimed at enhancing our
understanding of the pathophysiology of HA exposure and AMS and answering some of the
questions raised previously in this journal.[6] The following submissions were made to the
MoD Research Ethics Committee (MoDREC);

Protocol 578, Cardiovascular adaptation and recovery in chronic hypoxia. We have previously
assessed various methods of recording heart rate variability at HA [7] and this study aimed to
collect data on all the trekking teams, investigating changes in a range of physiological
variables including heart rate variability (HRV), central aortic blood pressures and pulmonary
artery pressures.

Protocol 580, Utility of BNP in diagnosing Acute Mountain Sickness (AMS). We have previous
published that brain natriuretic peptide (BNP) may have utility in the diagnosis of altitude
illness.[8-11] This study aims to recruit subjects who become unwell on expeditions at HA over
the next few years. This will enable us to establish whether BNP can be used to discriminate
between those with AMS or other conditions.

Protocol 608, The effects of progressive High Altitude on the development and burden of
significant cardiac arrhythmias using an implantable Cardiac Monitor (REVEAL Study). This
study used a small implantable (into the subcutaneous fat of the upper chest) cardiac
monitoring device, a “Reveal LINQ” made by Medtronic. This has the capability to record and
store information about heart rate and rhythm that can then be downloaded to a hard drive for
subsequent analysis. The marked hypoxaemia that occurs at altitude could be arrhythmogenic
and significant cardiac morbidity is known to occur at HA. This work builds on a smaller study
using the predecessor to the current Reveal device that suggested significant arrhythmias do
occur at HA.[12]

Protocol 624 Appetite responses during a high altitude expedition. Very little is known about
the underlying mechanisms regarding the anorexia and nausea suffered at HA, a topic
previously reviewed in this journal.[13] Reductions in appetite contribute to the degradation
that ultimately impairs performance at HA. This project investigated nutritional changes at
HA using food diaries, an assessment of gut hormones involved in appetite regulation and the
novel use at HA of wearable technology assessing continuous subcutaneous interstitial
glucose levels.

Protocol 623 Biomechanical changes in walking gait and balance at altitude. Changes in
balance may occur at HA and it has been suggested that changes in balance and walking
style may be related to the development of AMS and to the incidence of falls and accidents
on expeditions. This research examined joint position sense, balance and coordination
through a series of assessments including video assessment of gait and balance using a force
platform.

Protocol 663 Effects of iron status, manipulated using intravenous iron, on cardiopulmonary
physiology during ascent to very high altitude, assessed using echocardiography and selfreported functional performance scores. Exposure to the hypoxia of altitude leads to many
physiological changes and a key feature is hypoxic pulmonary vasoconstriction (HPV). HPV
increases pulmonary artery systolic pressure (PASP) and contributes to right ventricular strain

and exaggerated HPV is a feature of High Altitude Pulmonary Oedema. (HAPE). This study
used an intravenous iron infusion to optimise iron stores which at sea-level is known to
attenuate the HPV response to hypoxia.[14] There has been one previous trial that has also
shown a reduction in AMS following intravenous iron.[15] Participants were randomised to
receive iron or placebo and echocardiography used to assess their PASP in the field, while
Lake Louise scores collected allow researchers to assess any difference in AMS rates.

Protocol 586 Acclimation and acclimatisation: The effects of Exercise under Normobaric
(normal pressure) Hypoxic (reduced Fi02) conditions. We have been investigating the utility
of “pre-acclimatisation” in a hypoxic chamber in order to establish if such exposure can
improve performance on deployment to HA and reduce HA illness. This protocol compare the
effects of 5 days in a normobaric hypoxic chamber at simulated altitudes of between 4300 and
4800m with a control group. Echocardiographic variables, biochemical and endocrine markers
of physiological stress and indices of respiratory variables representing acclimatisation were
assessed pre- and post-hypoxic exposure as well as during the expedition in order to elucidate
any benefit. Additionally, rates of AMS have been assessed in the field to see if prior
acclimation can reduce the threat from HA illness.
Protocol 625 Application of Apnoeic training and physiological adaptations to altitude.
Free-divers expose themselves to periods of apnoea and prepare for this by a relatively simple
method of “breath-holding”. Apnoea training induces changes that could potentially be of
benefit at HA, including an increase in haematocrit, haemoglobin, erythropoietin and oxygen
saturation.[16] This protocol will employ a 6 week breath hold training programme and
compared this with a control group. Variables were assessed in the normobaric hypoxic
chamber pre-departure at a simulated 4800 m and while on the trek. These assessments
included spleen volume, oxygen saturation, haemoglobin, haematocrit, erythropoietin and
rates of AMS. Both protocol 586 and 625 benefit from access not only to the fixed normobaric
chamber at Leeds Beckett University but also a portable hypoxic chamber purchased with a
grant from Joint Medical Command via the DMS Research Steering Group.

Protocols were submitted to the RAF Scientific Advisory Committee (SAC) and subsequently
MoDREC during 2014 to ensure plenty of lead in time and that projects could be in place prior
to recruiting participants for the AT activity. The researchers acknowledge the efforts and
diligence of both the SAC and MODREC, whose input significantly enhanced the scientific
work proposed. Working with sports science specialists at Leeds Beckett University allowed
civilian colleagues to make use of an exceptional opportunity for research of this nature and
the military researchers to gain from their expertise and equipment. A recce to the area and

limited research conducted during February 2015 were hugely useful in finalising research
plans and resulted in some limited amendments to protocols.

Participants were all members of HM Forces taking part in an AT exercise and on duty.
Selection for this expedition was via Defence Instructions and Notices advertising the event,
advertisement through military climbing clubs and via word of mouth. Trekking teams were
selected by individual leaders and not by the overall expedition leadership or Principle
Investigators. Climbing teams were selected on the basis of previous climbing experience.
The climbers were split onto a main team of 12 experienced mountaineers to climb Dhaulagiri
and a high altitude development team (HADT), of 12 less experienced high altitude
mountaineers to climb Tukuche peak and gain experience. Once involved in the expedition
participants were invited to take part in specific research studies. Participants were invited to
participate in studies depending on time availability and geographical location before written
informed consent was obtained. Where teams were used as controls for an intervention group
every effort was made to match military backgrounds of individuals to ensure similar levels of
fitness.

All participants received a brief on mountain health including AMS and the military policy of
not using prophylactic acetazolamide (Diamox®) in this setting. Baseline data was collected
in the UK by a suitably qualified researcher before any pre-acclimatisation training took place.

On the expedition, data was collected by the subjects (daily diaries) and then at three research
camps established for the duration of the expedition at 3600m (IBC) , 4600m (Dhaulagiri BC)
and 5140m in the Hidden Valley. These camps had resident staff of two trained researchers
with at least one medically qualified in each location; additional researchers (military or Leeds
Beckett staff) accompanied specific trekking teams to collect specialist data (continuous
glucose measurements, cardiac echo, spleen ultrasound and conduct balance testing).

Climbing teams had background data collected at the time of Reveal LINQ device insertion or
when enrolled in the iron study. Any potential subject who could not comply with these timings
(usually for service reasons) were not included in these studies although data was collected
for non-intervention studies. All participants were low altitude dwellers, no trekking team
members had exposure to >1500m terrestrial altitude in the four weeks prior to the studies.

Research protocols undertaken by the climbers were developed mindful of minimising the
impact of research data collection when in country. All team members flew to Kathmandu via
long haul international flights and baseline data was collected the day after arrival or after 4

days in Kathmandu in the case of the advance party. This involved recording symptoms, SpO2
(Nonin Onyx, Nonin Medical Inc, Plymouth, Minnesota), haemaglobin (Haemocue, Haemocue
AB, Angelholm, Sweden), cardiac function and pulmonary artery pressures (Vivid I, GE
Healthcare, Amersham, UK) and was completed by one experienced cardiologist blinded to
the intervention (in the case of the iron study). The team then moved to 2750m by road, where
a further data collection period took place (day 4). After day 4 all altitude changes where
accomplished on foot carrying moderate loads (5-10Kg). Further altitude changes are given
in Table 1. Climbers completed an individual itinerary depending on self-declared fitness to
continue with the ascent profile and rest days taken as required. Subjects recorded daily Lake
Louise self-reported scores (LLS), AMSc scores, anxiety questionnaires (STAI), SpO2, heart
rate and HRV via iThlete app. The iThlete app records HRV over a one minute period of timed
ventilation (20 breaths) to give a number indicating HRV. The heart rate is recorded onto a
smart phone using the phones’ microphone and a finger probe. This number is based on root
mean squares of successive differences (RMSSD) of HRV and we have recently published
the validity of the iThlete app vs. conventional HRV measurement.[7] HRV recording were not
blinded and were taken by the individual first thing in the morning, in a seated position, before
food or caffeine wherever possible. Decisions regarding individual fitness to continue with the
itinerary or climb higher were made regardless of HRV reading (after consultation with a
medical officer who was also unaware of HRV reading where necessary). Borg Rating of
Perceived Exertion (RPE) for the “sessional exertion” each day was recorded each evening
and subjects asked to record their perception as to how hard the hardest bout of exercise that
day had been (on a scale of 6-20). Reveal Linq cardiac rhythm monitors were inserted into
members of the climbing team (Reveal LINQ, Medtronic, Dublin, Ireland). These devices were
inserted by a consultant cardiologist (CB) at Poole Hospital during January 2016. The device
automatically records any tachycardia, bradycardia or arrhythmia. Baseline data was collected
automatically via the Carelink system in the UK and downloaded every few days using a larger
programmer device in Nepal.

Table 1. Climbing team Itinerary and altitude changes
Day
0
1
2
3
4
5
6
7
8
9
10
10
11-24

Sleeping altitude
1400m
1400m
848m
2679m
2679m
3720m
3720m
4150m
4150m
4150m
5140m

Activity (evening Location
Arrive Kathmandu
Kathmandu – baseline data collected
Beni
Move to Marpha by vehicle
Marpha, subjects free to do own trekking acclimatisation
Trek Alu Bari Lower Camp, 3650m, o/n camp
Alu Bari Lower Camp, 3650m, Acclimatisation day.
Trek Yak Kharta
Yak Kharta, 4600m, acclimatisation day, o/n camp
Yak Kharta, 4600m, acclimatisation day, o/n camp
Trek Hidden Valley 4975m (via Dhampus Pass 5250m)
Hidden Valley, 4975m, acclimatisation day,
Hidden Valley basecamp for attempts on Dhampus peak 6035m
and Tukuche peak 6800m – individual itineraries

25
26-50

4800m

Team reduces to 12 and move to Dhaulagiri BC
Dhaulagiri BC – individual itineraries. Altitude of 7500m nachieved
by 5 team members.

51
52

Trek to Hidden Valley
Trek to Marpha
Rest Marpha
Rest Marpha
Drive to Pokhara
Drive to Kathmandu
Fly to UK

Trekking teams were invited to take part in studies 580, 578, 586, 623, 624 and 625.

Recruitment and interest in the studies was high.

Trekkers all arrived in Kathmandu by long haul air travel and travelled by road to 1123m before
attempting a trek of the Dhaulagiri circuit. Each team was accompanied by a medical officer
who advised on any changes in itinerary based on team or individual acclimatisation. Further
medical support was available at 3600m, 4650m and 5140m. The itinerary (Table 2) and
altitude profile (Figure 1) are below. Changes of itinerary where made as necessary when
trekkers showed signs of acute mountain sickness. Trekkers completed a daily recording of
LLS, AMSc scores, STAI, SpO2, heart rate. At 3600m, 4650m and 5140m heart rate variability
was recorded via a Checkmyheart™ HRM device (Daily Care Medical, Naihu, Taiwan). This
was a conventional single lead ECG and data were downloaded to a laptop to be analysed
offline by a cardiologist who was blinded to the individuals’ performance and LLS.

Table 2. Trekking team itinerary
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Day 7
Day 8
Day 9
Day 10
Day 11
Day 12
Day 13
Day 14
Day 15
Day 16

Activity
Fly from UK
Arrive Kathmandu
In Kathmandu. Sightseeing tour
Drive Beni via Pokhara
Drive Darbang and trek Riverside
Trek Jugepani 1456m
Trek Bagar
Trek Doban
Trek Sallagari
Trek Italian BC
Rest day at Italian BC
Trek to Japanese Camp
Trek Dhaulagiri Lower BC
Rest Day, Dhaulagiri Lower BC
Trek Hidden Valley
Rest day in Hidden Valley

Sleeping altitude

2017m
2430m
3107m
3619m
4072m
4600m
4600m
5140m
5140m

Results

129 military participants took part in the expedition including 7 research/medical staff. Two
trekkers were removed from the trail with minor illness before exposure to any significant
altitude. Three trekkers descended earlier than planned via IBC from higher on the trail; four
trekkers required extraction from the Hidden Valley by helicopter. One member of the HADT
withdrew on day 4 of the trek due to non-altitude related illness. Overall, 22 of the remaining
members of the HADT and main team reached 6035m and five reached 7500m on Dhaulagiri.

AMS was diagnosed by the Lake Louise or AMSc Scores from the daily symptoms scores
recorded. Subjects were included in analysis with a positive diagnosis of AMS if they took
drugs to aid acclimatisation or if they were evacuated by helicopter with no symptom scores
recorded. Data collection was completed well with relatively few missed data collection points.
The Dhaulagiri circuit is extremely remote and the satellite communication between camps
was patchy which reduced the ability to trouble shoot and provide rigorous oversight. Specific
research projects will be analysed individually and results submitted for publication in due
course.

Conclusion

The BSDMRE 2016 provided a unique opportunity to perform high quality research projects
in the most challenging and austere of situations. Strong collaboration between civilian
universities and military personnel drew on specialist expertise, maximised funding
opportunities and enabled a range of projects to be completed. The combination of AT and
research on an exercise of this scale was a novel undertaking and organisationally challenging
but will result in significant and militarily relevant outputs. After the enduring operations of
TELIC and HERRICK research strategies must now focus on support of the wider military as
we return to contingency. Remote, mountainous environments remain a safe haven for
potential enemies and presents significant challenges for non-acclimatised troops operating
in those areas. BSDMRE ranks as one of the largest participation HA research expeditions
ever conducted and continues a tradition of military leadership in this field.
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